dronabinol and am6545
dronabinol has been researched along with am6545 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Järbe, TU; LeMay, BJ; Makriyannis, A; Vadivel, SK; Vemuri, VK; Zvonok, A | 1 |
| Järbe, TU; Makriyannis, A; Nikas, SP; Shukla, VG; Tai, S; Vemuri, K | 1 |
| Bohn, LM; Han, GW; Hanson, MA; Ho, JH; Hua, T; Korde, A; Kufareva, I; Laprairie, RB; Li, S; Liu, ZJ; Makriyannis, A; Pu, M; Qu, L; Shui, W; Stahl, EL; Stevens, RC; Vemuri, K; Wu, B; Wu, Y; Zhao, Q; Zhao, S; Zhou, H; Zvonok, N | 1 |
Other Studies
3 other study(ies) available for dronabinol and am6545
| Article | Year |
|---|---|
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
Topics: Animals; Arachidonic Acids; Cannabinoids; Discrimination, Psychological; Dose-Response Relationship, Drug; Drinking; Dronabinol; Indoles; Ligands; Male; Morpholines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors | 2011 |
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
Topics: Animals; Body Temperature; Cannabinoid Receptor Antagonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Tolerance; Male; Mice; Morpholines; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance Withdrawal Syndrome | 2015 |
Crystal Structure of the Human Cannabinoid Receptor CB
Topics: Binding Sites; Cannabinoid Receptor Antagonists; Cannabinoids; Cannabis; Crystallography, X-Ray; Dronabinol; Endocannabinoids; Humans; Ligands; Morpholines; Protein Binding; Protein Conformation, alpha-Helical; Pyrazoles; Receptor, Cannabinoid, CB1 | 2016 |